170
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

When Should a Reversibility Test Be Performed on Patients with Early Stages of Asthma and Normal Spirometry?

, &
Pages 479-483 | Published online: 02 Jul 2009
 

Abstract

Subjects with bronchial asthmatic symptoms, forced expiratory volume in 1 second (FEV1) and FEV1/forced vital capacity [FVC] > 80% could show a positive reversibility test with salbutamol in about 25% of the cases. The aim of this study was to evaluate if a limit functional value for spirometry exists where a reversibility test using salbutamol, over this limit, is not necessary to confirm the diagnosis of asthma. Four hundred patients (mean age 31.12 ± 10.99) with asthmatic symptoms and normal spirometry (mean FEV1 96.06 ± 11.82%, mean FEV1/FVC 98.89 ± 6.03%) were recruited. The number of subjects with reversible airflow obstruction (RAO) was evaluated using the following different criteria of reversibility: FEV1 and FVC ≥ slant 12%, peak expiratory flow (PEF) ≥ slant 15%, FEF25 −75slant 35%, and at least one of these (ANY). In subjects with baseline FEV1 > 100% (150 patients), 26 (17.3%) patients showed a FEV1 increase > 12% and, among the criteria used, 45 patients (30%) showed ANY. In subjects with baseline FEV1/FVC > 100% (204 patients), 36 patients (17.6%) showed a FEV1 increase > 12% and 53 patients (26.8%) showed ANY. In subjects with baseline FEF25 −75 > 70% (209 patients), 26 (12.44%) and 49 (23.44%) patients, respectively, showed an increase in FEV1 > 12%, and ANY. In 56 patients with baseline cut-offs (evaluated together) FEV1 > 100%, FEV1/FVC > 100% and FEF25−75 > 70%, 10 patients (17.85%) showed a RAO with ANY. FEV1 > 121% or FEV1/FVC > 110.8% or FEF25 −75 > 110% were cut-off values identified in this study where no RAO subjects were found over these limits. In conclusion, baseline FEV1 > 100%, FEV1/FVC > 100% and FEF25 −75 > 70% cannot be considered cut-offs where it is not necessary to perform a reversibility test with a bronchodilator over these limits. It is improbable to find a positive reversibility test using salbutamol in patients with asthmatic symptoms and FEV1 > 121% or FEV1/FVC > 110.8% or FEF25 −75 > 110% to confirm the diagnosis of asthma.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,078.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.